EXPORT CITATION

Chapter-29 Gastrointestinal Drugs

BOOK TITLE: Drug Formulary

Author
1. George Mathew
2. Joseph Lincy
3. K Sujith
ISBN
9789352701896
DOI
10.5005/jp/books/14188_30
Edition
1/e
Publishing Year
2018
Pages
24
Author Affiliations
2. Pushpagiri College of Pharmacy, Thiruvalla, Kerala, India
3. Pushpagiri College of Pharmacy, Thiruvalla, Kerala, India
Chapter keywords
Aluminum hydroxide, domperidone, itopride, esomeprazole, lansoprazole, metoclopramide, mosapride, omeprazole, ondansetron, promethazine, pantoprazole, rabeprazole, ranitidine

Abstract

This chapter describes the gastrointestinal drugs, which include aluminum hydroxide, domperidone, itopride, esomeprazole, lansoprazole, metoclopramide, mosapride, omeprazole, ondansetron, promethazine, pantoprazole, rabeprazole, ranitidine, levosulpiride, dexrabeprazole, ramosetron, magnesium hydroxide, simethicone, famotidine, ilaprazole, oxethazaine, bacillus clausii, lactitol, ispaghula husk, L-ornithine L-aspartate, and glycopyrronium bromide. Nausea and vomiting associated with GI disorders, functional dyspepsia, and motility disorders such as hypomotility, and irritable bowel syndrome (IBD) are the indications of domperidone. Erosive esophagitis, nonsteroidal anti-inflammatory drugs (NSAIDs), Zollinger-Ellison syndrome, and GERD are the indications of esomeprazole. Peptic ulcer, hypersecretory conditions, acid-related dyspepsia, prevention and treatment of NSAID-related ulcers, and erosive esophagitis are the indications of lansoprazole.

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved